Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ceballos

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
The Journal of Pharmacology and Experimental Therapeutics|March 8, 2026
Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironmentCarla G Comanzo, Florencia Buatti Fagalde, Marina C Vera, et al.
Bone Marrow Transplantation|April 26, 2016
Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TCB Tessoulin, P Ceballos, P Chevallier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie CellulaireA Le Bourgeois, M Labopin, D Blaise, et al.
Bone Marrow Transplantation|April 5, 2016
Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)A Stamatoullas, P Brice, M S Gueye, et al.
Bone Marrow Transplantation|June 27, 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and EurocordS Nguyen, A Achour, L Souchet, et al.
Bone Marrow Transplantation|May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working PartyL Bento, A Boumendil, H Finel, et al.
Bone Marrow Transplantation|June 21, 2026
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMTA Kanellopoulos, M Labopin, A Spyridonidis, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
The Journal of Pharmacology and Experimental Therapeutics|March 8, 2026
Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironmentCarla G Comanzo, Florencia Buatti Fagalde, Marina C Vera, et al.
Bone Marrow Transplantation|April 26, 2016
Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TCB Tessoulin, P Ceballos, P Chevallier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie CellulaireA Le Bourgeois, M Labopin, D Blaise, et al.
Bone Marrow Transplantation|April 5, 2016
Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)A Stamatoullas, P Brice, M S Gueye, et al.
Bone Marrow Transplantation|June 27, 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and EurocordS Nguyen, A Achour, L Souchet, et al.
Bone Marrow Transplantation|May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working PartyL Bento, A Boumendil, H Finel, et al.
Bone Marrow Transplantation|June 21, 2026
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMTA Kanellopoulos, M Labopin, A Spyridonidis, et al.
Pageof 5